phase readout
saveNCT05811416: A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Relapsing-remitting Multiple Sclerosis (RRMS)
view source ↗
comments(0)
5-min edit window · permanent after that